有LP说：只和国资GP合作

Core Viewpoint - The investment landscape is increasingly favoring state-owned general partners (GPs) over private GPs, leading to a significant shift in the private equity market dynamics in China [2][4][10]. Group 1: Market Trends - Since last year, there has been a noticeable trend where limited partners (LPs) prefer to collaborate primarily with state-owned GPs due to their better performance and compliance assurance [2][3]. - The number of newly established private equity and venture capital funds in 2024 has decreased by 44.1% compared to the same period in 2023, with a total of 4,143 funds established [5]. - The total fundraising amount for newly registered funds in 2024 was approximately 41.21 billion yuan, representing a nearly 40% decline year-on-year [5]. Group 2: Fund Management and Competition - The number of private equity fund managers has decreased significantly, with 928 institutions being deregistered in 2024, which is about eight times the number of new registrations [6]. - The dominance of state-owned funds is evident, with over 90% of the mother fund industry being state-owned, and nearly 80% of government-guided funds [6][7]. - The competition for fundraising among private GPs has intensified, making it increasingly difficult for them to secure capital [4][10]. Group 3: Investment Environment - Many projects are now more inclined to accept investments from state-owned entities due to their financial backing and resource advantages [3]. - The current market environment has led to a situation where private GPs are struggling with fundraising, investment, and exit strategies, often resulting in a "zero exit" scenario for many institutions [10][11]. - The introduction of the "technology board" for bond markets aims to alleviate fundraising difficulties for private equity firms, allowing them to issue technology innovation bonds [12][13]. Group 4: Future Outlook - The issuance of technology innovation bonds has seen a rapid increase, with several equity investment institutions announcing bond issuances totaling over 20 billion yuan [15]. - There is hope that more patient capital will support private GPs in nurturing innovative enterprises, positioning them as a strategic force in the development of new productive forces in China [16].